FOR OPTIMAL PROTEIN QUALITY

ENDORSED EXPRESSION TECHNOLOGY
FOR GENE THERAPY VECTORS

NEWS

Cologne, Germany, July 22, 2015


CEVEC raises € 4.5 million in a financing round
to commercialize its leading CAP® based technologies